Clinical Cancer Research Molecular Diagnostics in Cancer Therapeutic Development: Fulfilling the Promise of Personalized Medicine Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adegboyega, P. A.
Right arrow Articles by Powell, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adegboyega, P. A.
Right arrow Articles by Powell, D. W.
Clinical Cancer Research Vol. 10, 5870-5879, September 1, 2004
© 2004 American Association for Cancer Research


Molecular Oncology, Markers, Clinical Correlates

Subepithelial Myofibroblasts Express Cyclooxygenase-2 in Colorectal Tubular Adenomas

Patrick A. Adegboyega1, Omiyosoye Ololade1, Jamal Saada2, Randy Mifflin2, John F. Di Mari2 and Don W. Powell2,3

Departments of 1 Pathology, 2 Internal Medicine, and 3 Physiology and Biophysics, University of Texas Medical Branch, Galveston, Texas

Purpose: Recent data support the hypothesis that the inducible isoform of cyclooxygenase (COX-2) plays a role in the early stages of colonic carcinogenesis and that nonsteroidal anti-inflammatory drugs (NSAIDs) retard the development of colon cancer by modulating COX-2. However, the cell types responsible for producing COX-2 in colorectal adenomas remain a subject of controversy.

Experimental Design: COX-2 expression in normal colonic mucosa (n = 50), hyperplastic polyps (n = 43), sporadic adenomas (n = 67), and invasive colonic adenocarcinoma (n = 39) was studied in formalin-fixed and paraffin-embedded tissue sections from endoscopy biopsy and colonic resection specimens. Immunohistochemistry (avidin-biotin complex technique with double immunolabeling) was used to identify the phenotypes of COX-2-producing cells.

Results: In colorectal adenomas, increased expression of COX-2 was detected and localized to {alpha} smooth muscle actin ({propto}SMA)-positive subepithelial stromal cells (myofibroblasts) in the periluminal region of the lamina propria in 63 (94%) of 67 cases. In contrast, in normal colonic mucosa and in hyperplastic polyps with intact epithelium, COX-2 expression was found only in macrophages and endothelial cells. In areas in which the surface epithelium was ulcerated in normal mucosa as well as hyperplastic or neoplastic polyps, COX-2 expression was increased in granulation tissue (and present in macrophages, endothelium, and myofibroblasts). In invasive carcinoma, COX-2 expression in myofibroblasts was limited to the adenomatous portion of the tumor and was detected in 62% of cases (n = 39). In addition, focal expression of COX-2 by malignant epithelial cells was observed in 23% of invasive adenocarcinoma.

Conclusions: These results show that increased COX-2 expression in sporadic adenoma of the colon is common and is localized specifically to subepithelial intestinal myofibroblasts. These findings further support the hypothesis that myofibroblasts are important target cells for NSAID-mediated chemoprevention of colorectal cancer.




This article has been cited by other articles:


Home page
Cancer Prevention ResearchHome page
N. L. Cho, M. Redston, A. G. Zauber, A. M. Carothers, J. Hornick, A. Wilton, S. Sontag, N. Nishioka, F. M. Giardiello, J. R. Saltzman, et al.
Aberrant Crypt Foci in the Adenoma Prevention with Celecoxib Trial
Cancer Prevention Research, June 1, 2008; 1(1): 21 - 31.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
U. Dougherty, A. Sehdev, S. Cerda, R. Mustafi, N. Little, W. Yuan, S. Jagadeeswaran, A. Chumsangsri, J. Delgado, M. Tretiakova, et al.
Epidermal Growth Factor Receptor Controls Flat Dysplastic Aberrant Crypt Foci Development and Colon Cancer Progression in the Rat Azoxymethane Model
Clin. Cancer Res., April 15, 2008; 14(8): 2253 - 2262.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. F. Di Mari, J. I. Saada, R. C. Mifflin, J. D. Valentich, and D. W. Powell
HETEs enhance IL-1-mediated COX-2 expression via augmentation of message stability in human colonic myofibroblasts
Am J Physiol Gastrointest Liver Physiol, October 1, 2007; 293(4): G719 - G728.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. M. Park, Y. Kanaoka, N. Eguchi, K. Aritake, S. Grujic, A. M. Materi, V. S. Buslon, B. L. Tippin, A. M. Kwong, E. Salido, et al.
Hematopoietic Prostaglandin D Synthase Suppresses Intestinal Adenomas in ApcMin/+ Mice
Cancer Res., February 1, 2007; 67(3): 881 - 889.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. I. Saada, I. V. Pinchuk, C. A. Barrera, P. A. Adegboyega, G. Suarez, R. C. Mifflin, J. F. Di Mari, V. E. Reyes, and D. W. Powell
Subepithelial Myofibroblasts are Novel Nonprofessional APCs in the Human Colonic Mucosa
J. Immunol., November 1, 2006; 177(9): 5968 - 5979.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
K. Nagata, K. Wada, A. Tatsuguchi, S. Futagami, K. Gudis, K. Miyake, T. Tsukui, and C. Sakamoto
Heregulin-{alpha} and heregulin-beta expression is linked to a COX-2-PGE2 pathway in human gastric fibroblasts
Am J Physiol Gastrointest Liver Physiol, June 1, 2006; 290(6): G1243 - G1251.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
D. W. Powell, P. A. Adegboyega, J. F. Di Mari, and R. C. Mifflin
Epithelial Cells and Their Neighbors I. Role of intestinal myofibroblasts in development, repair, and cancer
Am J Physiol Gastrointest Liver Physiol, July 1, 2005; 289(1): G2 - G7.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.